Image

Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis.

Recruiting
18 - 45 years of age
Female
Phase N/A

Powered by AI

Overview

This is a randomized clinical trial that will be carried out in women with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic-educational physiotherapy, which will combine therapeutic exercise with a pain education program, and the control group (CG) who will receive the pain education program.

The participants will be evaluated at three moments: before starting the study (T1), after the 8-week treatment program (T2) and after another 8 weeks of follow-up in which they will be encouraged to continue with the treatment (T3). The initial assessment will include a medical and physiotherapy history, and at T1, T2 and T3 the following will be assessed: pain, abdominopelvic mobility, muscle status, functionality, sexual function, quality of life, stress and biomarkers of chronic inflammation.

Eligibility

Inclusion Criteria:

  • Diagnosis of endometriosis made by imaging techniques (MRI or ultrasound) or by surgery.
  • A period of 3 months or more since the last surgery if they have undergone surgery.
  • Who are receiving hormone treatment and have their disease under control.
  • Persistent pelvic pain for at least 3 months.
  • With pain and hypertonus in the pelvic musculature, myofascial syndrome, vestibulodynia or pudendal neuropathy.
  • Consent to participate in the study
  • Capable of carrying out the follow-up of the study until the final visit.
  • Who have audiovisual resources and the internet at their disposal.

Exclusion Criteria:

  • Women in the menopausal phase
  • Women undergoing fertility treatment or planning to undergo fertility treatment in the next 3 months.
  • Pregnant women.
  • Women undergoing physiotherapy treatment or who have undergone physiotherapy treatment in the last 3 months.
  • Having suffered a fracture in the last 3 months in the lower limb that limits their functional capacity.
  • Cognitive illness that prevents correct comprehension of the exercises.
  • Musculoskeletal pathology or neuropathy in acute phase.
  • Having suffered or suffering from a neoplastic disease.
  • Untreated endometriosis
  • Acquired genital abnormalities of the pelvis or pelvic floor.
  • Women in a situation of litigation or economic compensation, or pending the granting of a degree of disability.
  • Severe mental illness (schizophrenia, borderline personality disorder, etc.)

Study details

Endometriosis, Chronic Pain, Women's Health

NCT06212349

University of Valencia

26 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.